Journal of nephrology
-
Journal of nephrology · Aug 2017
Multicenter StudyEffect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study.
The aim of this study was to evaluate, in a cohort of haemodialysis patients with atrial fibrillation (AF), the relationship between oral anticoagulant therapy (OAT) and mortality, thromboembolic events and haemorrhage. ⋯ In haemodialysis patients with AF, continuously taking warfarin is associated with a reduction of the risk of total and cardiovascular mortality.